A cross-species analysis method to analyze animal models' similarity to human's disease state

BackgroundAnimal models are indispensable tools in studying the cause of human diseases and searching for the treatments. The scientific value of an animal model depends on the accurate mimicry of human diseases. The primary goal of the current study was to develop a cross-species method by using the animal models' expression data to evaluate the similarity to human diseases' and assess drug molecules' efficiency in drug research. Therefore, we hoped to reveal that it is feasible and useful to compare gene expression profiles across species in the studies of pathology, toxicology, drug repositioning, and drug action mechanism.ResultsWe developed a cross-species analysis method to analyze animal models' similarity to human diseases and effectiveness in drug research by utilizing the existing animal gene expression data in the public database, and mined some meaningful information to help drug research, such as potential drug candidates, possible drug repositioning, side effects and analysis in pharmacology. New animal models could be evaluated by our method before they are used in drug discovery.We applied the method to several cases of known animal model expression profiles and obtained some useful information to help drug research. We found that trichostatin A and some other HDACs could have very similar response across cell lines and species at gene expression level. Mouse hypoxia model could accurately mimic the human hypoxia, while mouse diabetes drug model might have some limitation. The transgenic mouse of Alzheimer was a useful model and we deeply analyzed the biological mechanisms of some drugs in this case. In addition, all the cases could provide some ideas for drug discovery and drug repositioning.ConclusionsWe developed a new cross-species gene expression module comparison method to use animal models' expression data to analyse the effectiveness of animal models in drug research. Moreover, through data integration, our method could be applied for drug research, such as potential drug candidates, possible drug repositioning, side effects and information about pharmacology.

[1]  Chiranjib Chakraborty,et al.  Zebrafish: a complete animal model for in vivo drug discovery and development. , 2009, Current drug metabolism.

[2]  Chunxin Yang,et al.  Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way , 2010, Cell Stress and Chaperones.

[3]  N. Webster,et al.  Rottlerin inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes by uncoupling mitochondrial oxidative phosphorylation. , 2002, Endocrinology.

[4]  Christine C. Hudson,et al.  Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin , 2002, Molecular and Cellular Biology.

[5]  Yixue Li,et al.  Gene expression module-based chemical function similarity search , 2008, Nucleic acids research.

[6]  D. P. Wall,et al.  Detecting putative orthologs , 2003, Bioinform..

[7]  Dipnath Baidyaroy,et al.  Characterization of Inhibitor-Resistant Histone Deacetylase Activity in Plant-Pathogenic Fungi , 2002, Eukaryotic Cell.

[8]  H. Higashi,et al.  Mediation by intracellular calcium-dependent signals of hypoxic hyperpolarization in rat hippocampal CA1 neurons in vitro. , 1997, Journal of neurophysiology.

[9]  Malay Haldar,et al.  A conditional mouse model of synovial sarcoma: insights into a myogenic origin. , 2007, Cancer cell.

[10]  Yu Li,et al.  The protective effect of genistein postconditioning on hypoxia/reoxygenation-induced injury in human gastric epithelial cells , 2009, Acta Pharmacologica Sinica.

[11]  Consuelo Borras,et al.  Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARγ expression in cultured astrocytes , 2010, Brain Research.

[12]  Umar Mahmood,et al.  Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment , 2010, Proceedings of the National Academy of Sciences.

[13]  V Koneti Rao,et al.  Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS). , 2009, Experimental hematology.

[14]  Jie Rao,et al.  Control of estrogen receptor ligand binding by Hsp90 , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  Leonid Peshkin,et al.  Roundup: a multi-genome repository of orthologs and evolutionary distances , 2006, Bioinform..

[16]  J. Holder,et al.  PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. , 2000, Trends in pharmacological sciences.

[17]  D Beitner-Johnson,et al.  Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells. , 2001, Cellular signalling.

[18]  Richard E. White,et al.  Essential Role of the 90-Kilodalton Heat Shock Protein in Mediating Nongenomic Estrogen Signaling in Coronary Artery Smooth Muscle , 2009, Journal of Pharmacology and Experimental Therapeutics.

[19]  H. Parkinson,et al.  Large scale comparison of global gene expression patterns in human and mouse , 2010, Genome Biology.

[20]  M. Ihnat,et al.  Docosahexaenoic Acid Inhibits Superoxide Dismutase 1 Gene Transcription in Human Cancer Cells: The Involvement of Peroxisome Proliferator-Activated Receptor α and Hypoxia-Inducible Factor-2α Signaling , 2009, Molecular Pharmacology.

[21]  Gabriela Chiosis,et al.  Heat shock protein 90: translation from cancer to Alzheimer's disease treatment? , 2008, BMC Neuroscience.

[22]  J. Olson,et al.  Conservation of Regional Gene Expression in Mouse and Human Brain , 2007, PLoS genetics.

[23]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[24]  D. Geschwind,et al.  Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease , 2009, Nature Medicine.

[25]  E. Schlenker,et al.  In hamsters dopamine D2 receptors affect ventilation during and following intermittent hypoxia. , 2007, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[26]  M. Yaqoob,et al.  Modulation of hypoxia-induced calpain activity in rat renal proximal tubules. , 1996, Kidney international.

[27]  Esther T. Chan,et al.  Conservation of core gene expression in vertebrate tissues , 2009, Journal of biology.

[28]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[29]  Xudong Tang,et al.  Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1α and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells , 2005, Molecular Cancer Therapeutics.

[30]  Valérie Gailus-Durner,et al.  Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells , 2011, Nature communications.

[31]  S. Horvath,et al.  Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways , 2010, Proceedings of the National Academy of Sciences.

[32]  J. Hogenesch,et al.  Gene expression profiling of hypoxia signaling in human hepatocellular carcinoma cells. , 2005, Physiological genomics.

[33]  J. Holder,et al.  PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer , 2000 .

[34]  B. Spiegelman,et al.  15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. , 1995, Cell.

[35]  Paul Greengard,et al.  Estrogen Lowers Alzheimer β-Amyloid Generation by Stimulatingtrans-Golgi Network Vesicle Biogenesis* , 2002, The Journal of Biological Chemistry.

[36]  Kurt Zatloukal,et al.  Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo , 2010, Molecular Cancer.

[37]  L. Zon,et al.  In vivo drug discovery in the zebrafish , 2005, Nature Reviews Drug Discovery.

[38]  V. Lee,et al.  Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinase. , 2009, Biochemistry.

[39]  Ravichandran Ramasamy,et al.  Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. , 2010, Circulation research.

[40]  Patricia Renard,et al.  Role of ERK and calcium in the hypoxia‐induced activation of HIF‐1 , 2003, Journal of cellular physiology.

[41]  Robin D Dowell,et al.  The similarity of gene expression between human and mouse tissues , 2011, Genome Biology.

[42]  K. Shudo,et al.  Towards Retinoid Therapy for Alzheimer’s Disease , 2009, Current Alzheimer research.

[43]  R. Tibshirani,et al.  Disease signatures are robust across tissues and experiments , 2009, Molecular systems biology.

[44]  Mallika Singh,et al.  Using Genetically Engineered Mouse Models of Cancer to Aid Drug Development: An Industry Perspective , 2006, Clinical Cancer Research.

[45]  B. Gaston,et al.  Akt-mediated activation of HIF-1 in pulmonary vascular endothelial cells by S-nitrosoglutathione. , 2007, American journal of respiratory cell and molecular biology.

[46]  C. Sohaskey,et al.  Nitrate Enhances the Survival of Mycobacterium tuberculosis during Inhibition of Respiration , 2008, Journal of bacteriology.

[47]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[48]  A. Dicker,et al.  Zebrafish: An Emerging Model System for Human Disease and Drug Discovery , 2007, Clinical pharmacology and therapeutics.

[49]  Chen,et al.  Is a Ligand for the Adipocyte Determination Factor PPARy , 2004 .

[50]  Sean F. Eddy,et al.  The Role of Hypoxia in 2-Butoxyethanol–Induced Hemangiosarcoma , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  Jane B Shofer,et al.  Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[52]  Y Kuge,et al.  Retinoic acid stimulates erythropoietin gene transcription in embryonal carcinoma cells through the direct repeat of a steroid/thyroid hormone receptor response element half-site in the hypoxia-response enhancer. , 2000, Blood.

[53]  J. Chin,et al.  Selecting a mouse model of Alzheimer's disease. , 2010, Methods in molecular biology.

[54]  Robert Hoehndorf,et al.  New approaches to the representation and analysis of phenotype knowledge in human diseases and their animal models. , 2011, Briefings in functional genomics.